甲酰四氢叶酸延迟给药对小鼠氨甲蝶呤抗白血病疗效的影响。 - Suppr

Suppr

超能文献

Effect of delayed administration of citrovorum factor on the antileukemic effectiveness of aminopterin in mice.

作者信息

GOLDIN A, MANTEL N, GREENHOUSE S W, VENDITTI J M, HUMPHREYS S R

出版信息

Cancer Res. 1954 Jan;14(1):43-8.

PMID:13126932

Abstract

摘要

相似文献

Effect of delayed administration of citrovorum factor on the antileukemic effectiveness of aminopterin in mice.

Cancer Res. 1954 Jan;14(1):43-8.

Factors influencing the specificity of action of an antileukemic agent (aminopterin); multiple treatment schedules plus delayed administration of citrovorum factor.

Cancer Res. 1955 Jan;15(1):57-61.

[Therapeutic possibilities of combined citrovorum factoraminopterin therapy in acute leukemia].

G Ital Chemioter. 1954 Jan-Mar;1(1):156-60.

[Clinical studies on the metabolism of folic acid and the citrovorum factor. III. Metabolism of folic acid following intravenous injection of PGA. Appendix: Some observations on the effect of aminopterin upon folic acid metabolism and on heat labile citrovorum factor].

Naika Hokan. 1961;8:530-41.

Combination therapy of chloroleukemia in mice with aminopterin and citrovorum factor.

Acta Haematol. 1953 Sep;10(3):180-5. doi: 10.1159/000204423.

[Associated citrovorum factor-aminopterin treatment in acute leukemia].

Sang. 1955;26(4):426-34.

[Protection of intestinal mitoses against the radiomimetic action of aminopterin by the citrovorum factor].

C R Seances Soc Biol Fil. 1951 Sep;145(17-18):1442-3.

Studies on the reversal of aminopterin toxicity in the rat with citrovorum factor, folacin and related compounds.

J Nutr. 1953 May;50(1):101-15. doi: 10.1093/jn/50.1.101.

[Therapeutic experimentation with citrovorum factor in acute leukemia; folic acid deficiency as the etiopathogenic factor essential in transformation of chronic stage of leukemia into acute].

Riv Crit Clin Med. 1953 Jun 30;52(3):168-80.

An analysis of dose-response for animals treated with aminopterin and citrovorum factor.

J Natl Cancer Inst. 1953 Jun;13(6):1463-71.

引用本文的文献

Osteosarcoma: evolution of treatment paradigms.

Sarcoma. 2013;2013:203531. doi: 10.1155/2013/203531. Epub 2013 May 27.

Glucarpidase to combat toxic levels of methotrexate in patients.

Ther Clin Risk Manag. 2012;8:403-13. doi: 10.2147/TCRM.S30135. Epub 2012 Nov 22.

THE EFFECT OF DELAYED ADMINISTRATION OF FOLINIC ACID ON IMMUNOLOGICAL INHIBITION BY METHOTREXATE.

Immunology. 1965 Mar;8(3):251-9.

Reduction in the toxicity of aminopterin--monoclonal-antibody conjugates by leucovorin.

Cancer Immunol Immunother. 1994 Aug;39(2):135-9. doi: 10.1007/BF01525319.

Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols.

J Cancer Res Clin Oncol. 1984;108(1):87-97. doi: 10.1007/BF00390979.

Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.

Jpn J Cancer Res. 1989 Apr;80(4):394-9. doi: 10.1111/j.1349-7006.1989.tb02325.x.

Methotrexate (MTX) concentration in tumors following low-dose MTX.

Cancer Chemother Pharmacol. 1987;20(1):78-80. doi: 10.1007/BF00252965.

Clinical pharmacokinetics of methotrexate.

Clin Pharmacokinet. 1978 Jan-Feb;3(1):1-13. doi: 10.2165/00003088-197803010-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验